$3.43
0.020.59%
At close: Dec 16, 4:00 PM EST
$3.50
0.072.04%
After Hours: 5:15 PM EST
Comments
Loading...
Latest Rocket Pharmaceuticals Stock News | NASDAQ:RCKT | Benzinga
Get the latest news on Rocket Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Rocket Pharmaceuticals performance
Categories: All
Tuesday, November 18, 2025
Thursday, November 06, 2025
Tuesday, November 04, 2025
Tuesday, October 14, 2025
- FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock
- Chardan Capital Maintains Buy on Rocket Pharm...
- Domino's Pizza Posts Upbeat Results, Joins Astria Therapeutics, Albertsons Companies, Polaris And Other Big Stocks Moving Higher On Tuesday
- Rocket Pharmaceuticals shares are trading hig...
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- The FDA Has Accepted The Resubmission Of Rock...
Friday, October 03, 2025
Thursday, September 04, 2025
Monday, August 25, 2025
Friday, August 22, 2025
Thursday, August 21, 2025
Wednesday, August 20, 2025
- B of A Securities Upgrades Rocket Pharmaceuti...
- Chardan Capital Maintains Buy on Rocket Pharm...
- TJX Posts Better-Than-Expected Earnings, Joins Rocket Pharmaceuticals, Guess? And Other Big Stocks Moving Higher On Wednesday
- FDA Lifts Rocket Pharmaceuticals Study Hold For Rare Disease Gene Therapy
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Rocket Pharmaceuticals shares are trading hig...
- Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
- The FDA Lifts Clinical Hold On Rocket Pharmac...
Monday, August 11, 2025
Friday, August 08, 2025
Thursday, August 07, 2025
Wednesday, July 30, 2025
Friday, July 25, 2025
Thursday, July 24, 2025
Thursday, July 17, 2025
Monday, June 30, 2025
Tuesday, June 17, 2025
Tuesday, June 03, 2025
Saturday, May 31, 2025
Wednesday, May 28, 2025
- Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty
- B of A Securities Maintains Buy on Rocket Pha...
- BMO Capital Maintains Outperform on Rocket Ph...
- Scotiabank Maintains Sector Outperform on Roc...
- Leerink Partners Downgrades Rocket Pharmaceut...
- Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday
